Contact Dr. Anita Lyn Sabichi
713-798-3750
Dr. Anita Lyn Sabichi
Dr. Anita Lyn Sabichi is a medical oncologist specializing in translational biology and molecular medicine at the Baylor College of Medicine in Houston.
- Medical Oncologist
- Pleural Specialist
- Expertise:
-
Research
- Speciality:
-
Medical Oncology
- Gender:
-
Female
- Language:
-
English
Primary Location
- Doctors At This Location
-
Dr. Lorraine D. CornwellAssociate Professor of Surgery at Baylor College of Medicine
Dr. R. Taylor RipleyThoracic Surgeon
Dr. Eugene ChoiSurgical Oncologist
Dr. Pavan Mukesh JhaveriRadiation Oncologist
Free Mesothelioma Treatment Guide
"Most helpful, steered us in the right direction for treatmen...." see more
Elaine C. - Mesothelioma Patient
"Because of their guidance, I was able to navigate getting my...." see more
Deanna B. - Daughter of a Mesothelioma Patient
"Hearing the news about my mother's diagnosis was heartbreaki...." see more
Danielle W. - Daughter of a Mesothelioma Patient
"My son Carlos was diagnosed with this terrible and unknown d...." see more
Martha M. - Mother of a Mesothelioma Patient
"Extremely communicative and helped my dad get an appointment...." see more
Sunni H. - Loved One of a Mesothelioma Patient
"Danielle DiPietro was an invaluable resource for me. Her sug...." see more
Deborah C. - Spouse of a Mesothelioma Patient
"I was very grateful and appreciative of Dr. Smart from The M...." see more
Kimberlin C. - Spouse of a Mesothelioma Patient
"In January of 2016, my husband was diagnosed with peritoneal...." see more
Gloria R. - Spouse of a Mesothelioma Patient
- Expertise:
-
Research
- Speciality:
-
Medical Oncology
- Gender:
-
Female
- Language:
-
English
- Primary Location
-
Sabichi is involved in experimental therapeutics of lung, head and neck cancers. She helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.
Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.
In 2021, Dr. Sabichi published a research study on anti-PD-1 monotherapy, outlining the clinical benefits as first-line therapy for malignant pleural mesothelioma patients.
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
Mesothelioma Trust Funds
